Determinants of SARS-CoV-2 nasopharyngeal testing in a rural community sample susceptible of first infection: the CHRIS COVID-19 study

References

• Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020 May 1;20(5):533–534.
   PubMed Web of Science ®Google Scholar
• Rostami A, Sepidarkish M, Leeflang MMG, et al. SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis. Clin Microbiol Infect. 2021 Mar 1;27(3):331–340. DOI:10.1016/j.cmi.2020.10.020
   PubMed Web of Science ®Google Scholar
• Álvarez-Antonio C, Meza-Sánchez G, Calampa C, et al. Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study. Lancet Glob Health. 2021 Jul 1;9(7):e925–31. DOI:10.1016/S2214-109X(21)00173-X
   PubMed Web of Science ®Google Scholar
• Melotti R, Scaggiante F, Falciani M, et al. Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena valley. Epidemiol Infect. 2021;149:e149.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Hwang H, Hong H, et al. A systematic review and meta-analysis of regional risk factors for critical outcomes of COVID-19 during early phase of the pandemic. Sci Rep. 2021 May 7;11(1):9784.
   PubMedGoogle Scholar
• Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020 Aug 1;81(2):e16–25. DOI:10.1016/j.jinf.2020.04.021
   PubMed Web of Science ®Google Scholar
• Gesesew HA, Koye DN, Fetene DM, et al. Risk factors for COVID-19 infection, disease severity and related deaths in Africa: a systematic review. BMJ Open. 2021 Feb 1;11(2):e044618. DOI:10.1136/bmjopen-2020-044618
   PubMed Web of Science ®Google Scholar
• Booth A, Reed AB, Ponzo S, et al. Population risk factors for severe disease and mortality in COVID-19: a global systematic review and meta-analysis. PLoS ONE. 2021 Mar 4;16(3):e0247461. DOI:10.1371/journal.pone.0247461
   PubMed Web of Science ®Google Scholar
• ECDC: risk factors and risk groups [Internet]. [cited 2021 Nov 23]. Available from: https://www.ecdc.europa.eu/en/covid-19/latest-evidence/risk-factors-risk-groups
   Google Scholar
• Allen WE, Altae-Tran H, Briggs J, et al. Population-scale longitudinal mapping of COVID-19 symptoms, behaviour and testing. Nat Hum Behav. 2020 Sep;4(9):972–982.
   PubMed Web of Science ®Google Scholar
• Chen X, Chen Z, Azman AS, et al. Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis. Lancet Glob Health. 2021 Mar 8;9(5):e598–609. Doi:10.1016/S2214-109X(21)00026-7
   PubMed Web of Science ®Google Scholar
• Rentsch CT, Kidwai-Khan F, Tate JP, et al. Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: a nationwide cohort study. PLOS Med. 2020 Sep 22;17(9):e1003379. DOI:10.1371/journal.pmed.1003379
   PubMed Web of Science ®Google Scholar
• Lieberman-Cribbin W, Tuminello S, Flores RM, et al. Disparities in COVID-19 testing and positivity in New York city. Am J Preventive Med. 2020 Sep 1;59(3):326–332.
   PubMed Web of Science ®Google Scholar
• Sun N, Hua CL, Qiu X, et al. Determinants of COVID-19 testing among late middle-aged and older adults: applying the health belief model. Aging Health Res. 2022 Jun 1;2(2):100066.
   PubMedGoogle Scholar
• Ladwig KH, Marten-Mittag B, Formanek B, et al. Gender differences of symptom reporting and medical health care utilization in the German population. Eur J Epidemiol. 2000 Jun;16(6):511–518.
   PubMed Web of Science ®Google Scholar
• Ballering AV, Oertelt-Prigione S, Olde Hartman TC, et al. Lifelines corona research initiative. sex and gender-related differences in covid-19 diagnoses and SARS-CoV-2 testing practices during the first wave of the pandemic: the dutch lifelines COVID-19 cohort study. J Womens Health (Larchmt). 2021 Dec;30(12):1686–1692.
   PubMed Web of Science ®Google Scholar
• Rostami A, Sepidarkish M, Fazlzadeh A, et al. Update on SARS-CoV-2 seroprevalence: regional and worldwide. Clin Microbiol Infect. 2021 Dec 1;27(12):1762–1771. DOI:10.1016/j.cmi.2021.09.019
   PubMed Web of Science ®Google Scholar
• Stefanelli P, Bella A, Fedele G, et al. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study. Clin Microbiol Infect. 2021 Apr 1;27(4):e633.1–633.7. DOI:10.1016/j.cmi.2020.11.013
   Web of Science ®Google Scholar
• Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020 Oct 23;370(6515):eabd4585. DOI:10.1126/science.abd4585
   PubMed Web of Science ®Google Scholar
• Pagani G, Conti F, Giacomelli A, et al. Seroprevalence of SARS-CoV-2 significantly varies with age: preliminary results from a mass population screening. J Infect. 2020 Dec;81(6):e10–2.
   PubMed Web of Science ®Google Scholar
• Pelagatti M, Maranzano P. Assessing the effectiveness of the Italian risk-zones policy during the second wave of COVID-19. Health Policy. 2021 Jul 31;125(9):1188–1199.
   PubMed Web of Science ®Google Scholar
• Stillman S, Tonin M Communities and testing for covid-19 [internet]. Report No.: ID 3762882. Rochester, NY: Social Science Research Network; 2021 Jan. [cited 2021 Nov 23]. Available from: https://papers.ssrn.com/abstract=3762882
   Google Scholar
• Pattaro C, Barbieri G, Foco L, et al. Prospective epidemiological, molecular, and genetic characterization of a novel coronavirus disease in the val venosta/vinschgau: the CHRIS COVID-19 study protocol. Pathog Glob Health. 2021 Oct 12;116(2):128–136. doi:10.1080/20477724.2021.1978225
   PubMed Web of Science ®Google Scholar
• Pattaro C, Gögele M, Mascalzoni D, et al. The cooperative health research in south tyrol (CHRIS) study: rationale, objectives, and preliminary results. J Transl Med. 2015 Nov 5;13(1):348. DOI:10.1186/s12967-015-0704-9
   PubMedGoogle Scholar
• Fitzmaurice GM, Laird N, Ware JH. Applied longitudinal data analysis. 2nd. Hoboken, New Jersey, USA: John Wiley & Sons; 2012. Wiley series in probability and statistics.
   Google Scholar
• Nakagawa S, Schielzeth H, O’Hara RB. A general and simple method for obtaining R2 from generalized linear mixed-effects models. Methods Ecol Evol. 2013;4(2):133–142.
   Web of Science ®Google Scholar
• Hedeker D, Shc du Toit, Demirtas H, et al. A note on marginalization of regression parameters from mixed models of binary outcomes. Biometrics. 2018;74(1):354–361.
   PubMed Web of Science ®Google Scholar
• Audigier V, White IR, Jolani S, et al. Multiple Imputation for multilevel data with continuous and binary variables. Stat Sci. 2018 May;33(2):160–183.
   Web of Science ®Google Scholar
• Spratt M, Carpenter J, Sterne JAC, et al. Strategies for multiple imputation in longitudinal studies. Am J Epidemiol. 2010 Aug 15;172(4):478–487. DOI:10.1093/aje/kwq137
   PubMed Web of Science ®Google Scholar
• R Core Team. (2020). R: a language and environment for statistical computing. [Internet]. Vienna, Austria: R Foundation for Statistical Computing; Available from: https://www.R-project.org/
   Google Scholar
• Barbieri G, Gögele M, Melotti R, et al. A random population sample and 10 follow-ups: one year of COVID-19 pandemic seen through the CHRIS COVID-19 study XI Congresso nazionale SISMEC; 2021 Sep 15-18; Bari, Italy. p. 174–176. https://www.sismec.info/images/congresso_2021/Atti_Convegno_SISMEC_2021_red.pdf
   Google Scholar
• Tao R, Downs J, Beckie TM, et al. Examining spatial accessibility to COVID-19 testing sites in Florida. Annals of GIS. 2020 Oct 1;26(4):319–327.
   Web of Science ®Google Scholar
• Ward S, Lindsley A, Courter J, et al. Clinical testing for COVID-19. J Allergy Clin Immunol. 2020 Jul;146(1):23–34.
   PubMed Web of Science ®Google Scholar
• Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases. Interim guidance. [Internet]. [cited 2021 Nov 23]. Available from: https://apps.who.int/iris/bitstream/handle/10665/331329/WHO-COVID-19-laboratory-2020.4-eng.pdf?sequence=1&isAllowed=y
   Google Scholar
• ECDC. COVID-19 testing strategies and objectives [Internet]. [cited 2021 Nov 23]. Available from: https://www.ecdc.europa.eu/en/publications-data/covid-19-testing-strategies-and-objectives
   Google Scholar
• Bergman J, Ballin M, Nordström A, et al. Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study. Eur J Epidemiol. 2021 Mar 1;36(3):287–298.
   PubMed Web of Science ®Google Scholar
• Lan FY, Filler R, Mathew S, et al. COVID-19 symptoms predictive of healthcare workers’ SARS-CoV-2 PCR results. PLoS ONE. 2020 Jun 26;15(6):e0235460. DOI:10.1371/journal.pone.0235460
   PubMed Web of Science ®Google Scholar
• Nguyen LH, Drew DA, Graham MS, et al. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health. 2020 Sep;5(9):e475–83.
   PubMed Web of Science ®Google Scholar
• Wynants L, Van Calster B, Collins GS, et al. Prediction models for diagnosis and prognosis of COVID-19 infection: systematic review and critical appraisal. BMJ. 2020 Apr 7;369:m1328. DOI:10.1136/bmj.m1328.
   PubMedGoogle Scholar
• Jehi L, Ji X, Milinovich A, et al. Individualizing risk prediction for positive coronavirus disease 2019 testing. Chest. 2020 Oct;158(4):1364–1375.
   PubMed Web of Science ®Google Scholar
• Binnicker MJ, Kraft CS. Challenges and controversies to testing for COVID-19. J Clin Microbiol. 2020;58(11):e01695–20.
   PubMed Web of Science ®Google Scholar
• Manabe YC, Sharfstein JS, Armstrong K. The need for more and better testing for COVID-19. JAMA. 2020 Dec 1;324(21):2153–2154.
   PubMed Web of Science ®Google Scholar